Article metrics

Original research
Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: September 2022 to October 2022

AbstractFullPdf
Sep 2022448450109
Oct 202234934964
Total797799173